TRAIL and TRAIL receptors in patients with laryngeal cancer.

about

Correlation between Polymorphism of TRAIL Gene and Condition of Intervertebral Disc Degeneration.

P2860

Q35939523-5A725E60-E992-40BC-B819-731B8C62102F

P2860

TRAIL and TRAIL receptors in patients with laryngeal cancer.

Item

http://www.wikidata.org/entity/Q45874298

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@en

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@nl

type

Item

label

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@en

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@nl

prefLabel

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@en

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@nl

P1476

TRAIL and TRAIL receptors in patients with laryngeal cancer.

@en

P2093

Atila Gungor

http://www.w3.org/2001/XMLSchema#string

Dogan Pinar

http://www.w3.org/2001/XMLSchema#string

Evren Erkul

http://www.w3.org/2001/XMLSchema#string

Hakan Cincik

http://www.w3.org/2001/XMLSchema#string

Mustafa Alparslan Babayigit

http://www.w3.org/2001/XMLSchema#string

Onuralp Kurt

http://www.w3.org/2001/XMLSchema#string

Zafer Kucukodaci

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis

Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data.

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

TRAIL-induced signalling and apoptosis.

Treatment of hypopharyngeal carcinoma with primary chemoradiotherapy: functional morbidity.

TRAIL-based therapeutic approaches for the treatment of pediatric malignancies.

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

P304

E535-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.24035

http://www.w3.org/2001/XMLSchema#string

P478

38 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25810124

http://www.w3.org/2001/XMLSchema#string

P921

Bagtingan

TRAIL and TRAIL receptors in patients with laryngeal cancer.

about

P2860

P2860

TRAIL and TRAIL receptors in patients with laryngeal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921